Search for 'Provider:Cancer cell,'

Acute myeloid leukemia and transcription factors: role of erythroid Krüppel-like factor (EKLF).

By Ayala Díaz, Rosa María | Gilsanz Rodríguez, Florinda | Martínez López, Joaquín. Cancer Cell International, 2012 . 12(1):25. , Formato Vancouver: Ayala R, Martínez-López J, Gilsanz F. Acute myeloid leukemia and transcription factors: role of erythroid Krüppel-like factor (EKLF). Cancer Cell Int. 2012 Jun 7;12(1):25.

Place Hold on Acute myeloid leukemia and transcription factors: role of erythroid Krüppel-like factor (EKLF).

RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway.

By Ortiz Romero, Pablo Luis | Rodríguez Peralto, José Luis. Cancer cell, 2014 . 26(1):61-76. , Formato Vancouver: Alonso Curbelo D, Riveiro Falkenbach E, Pérez Guijarro E, Cifdaloz M, Karras P, Osterloh L et al. RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway. Cancer Cell. 2014 Jul 14;26(1):61-76.

Place Hold on RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway.

hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic Malignancies.

By Rapado Martínez, Inmaculada | Martínez López, Joaquín. Cancer cell, 2015 . 28(4):486-499. , Formato Vancouver: Gallardo M, Lee HJ, Zhang X, Bueso Ramos C, Pageon LR, McArthur M et al. hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic Malignancies. Cancer Cell. 2015 Oct 12;28(4):486-499.

Place Hold on hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic Malignancies.